X0306 4 2021-06-07 false 0001517022 Akebia Therapeutics, Inc. AKBA 0001379970 GILMAN STEVEN C C/O AKEBIA THERAPEUTICS, INC. 245 FIRST ST. CAMBRIDGE MA 02142 true false false false Common Stock 2021-06-07 4 S false 4567.00 3.3202 D 47997.00 D This sale was made pursuant to a 10b5-1 trading plan to cover tax withholding obligations in connection with the vesting and settlement of 100% of the Reporting Person's restricted stock units granted on June 5, 2020. This transaction was executed in multiple trades at prices ranging from $3.3201 USD to $3.325 USD; the price reported above reflects the weighted average sale price. /s/ Nicole R. Hadas, attorney-in-fact for Steven C. Gilman 2021-06-09